Skba Capital Management LLC Has $13.73 Million Stake in Kenvue Inc. $KVUE

Skba Capital Management LLC increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 24.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 845,775 shares of the company’s stock after buying an additional 163,900 shares during the period. Kenvue accounts for 1.9% of Skba Capital Management LLC’s holdings, making the stock its 22nd biggest holding. Skba Capital Management LLC’s holdings in Kenvue were worth $13,727,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of KVUE. Salomon & Ludwin LLC acquired a new position in Kenvue in the third quarter valued at approximately $25,000. NBT Bank N A NY lifted its position in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC boosted its stake in Kenvue by 705.2% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares during the last quarter. Golden State Wealth Management LLC increased its holdings in Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. UBS Group increased their price target on Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Citigroup raised their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Finally, Barclays upped their price target on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $19.50.

Insider Transactions at Kenvue

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.17% of the company’s stock.

Kenvue Stock Performance

NYSE:KVUE opened at $18.17 on Wednesday. The company has a market capitalization of $34.83 billion, a price-to-earnings ratio of 23.60, a PEG ratio of 4.33 and a beta of 0.51. The business has a 50 day moving average of $17.78 and a 200 day moving average of $17.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same quarter in the prior year, the company earned $0.26 EPS. The firm’s revenue was up 3.2% on a year-over-year basis. On average, sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is currently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.